Calcium channel blockers in psychiatry

Progress in Drug Research

Volumn 47, Issue , 1996, Pages 279-292

  Hollister, Leo E ^a   Garza Trevino, Enrique S ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b San Antonio Mood Disorders Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; LITHIUM; NIFEDIPINE; NIMODIPINE; VALPROIC ACID; VERAPAMIL;

BIPOLAR DEPRESSION; DEMENTIA; DRUG RESISTANCE; GILLES DE LA TOURETTE SYNDROME; HUMAN; HUNTINGTON CHOREA; MAJOR DEPRESSION; PANIC; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

EID: 0029850099     PISSN: 0071786X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-0348-8998-8_8     Document Type: Review

References (59)

1. Carman, J.S. and Wyatt, R.J.: Calcium: pacesetting the periodic psychoses. Am. J. Psychiatry 136, 1035-9 (1979).
2. Gould, R.J., Murphy, K.M., Reynolds, I.J. and Syder, S.H.: Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists. Proc. Natl. Acad. Sci. USA. 80, 5122-5125 (1983).
3. Rasmussen, H..: The cycling of calcium as an intracellular messenger. Scientific American (Oct), 66-73 (1989).
4. Swann, A.: Practical management of depressive and manic episodes. In: Garza-Trevino (Ed.): Medical Psychiatry: Theory and Practice 1, 8. River Edge, N.J., World Scientific, 1989.
5. Tan, C.H., Javors, M.A., Seleshi, E., Lowrimore, P.A. and Bowden, C.L.: Effects of lithium on platelet ionic intracellular calcium concentration in patients with bipolar disorder and healthy controls. Life Sci. 46, 1175-1180 (1990).
6. Caillard, V. and Masse, G.: Traitement de la manie par un inhibiteur calcique. Etude preliminaire, L'ence;phale VVI, 587-594 (1982).
7. Dubovsky, S.L., Franks, R.D., Lifschitz, M. and Coe, P.: Effectiveness of verapamil in the treatment of mania. Am. J. Psychiat. 139, 502-504 (1982).
8. Goldstein, J.A.: Calcium and neurotransmission. Biol. Psychiatry 19, 406 (1984).
9. Giannini, A.J., Houser, W.L. Jr., Loiselle, R.H., Giannini, M.C. and Price, W.A.: Antimanic effects of verapamil. Am. J. Psychiatry 141, 1602-1603 (1984).
10. Gitlin, M.J. and Weisse, J.: Verapamil as maintenance treatment in bipolar illness: A case report. J. Clin. Psychopharmacol. 4, 341-343 (1984).
11. Caillard, V.: Treatment of mania using a calcium antagonist-preliminary trial. Neuropsychobiology 14, 23-26 (1985).
12. Giannini, A.J., Loiselle, R.H., Price, W.A. and Giannini, M.C.: Comparison of antimanic efficacy of clonidine and verapamil. J. Clin. Pharmacol. 25, 307-308 (1985).
13. Dubovsky, S., Franks, R.D., Allen, S. and Murphy, J.: Calcium antagonists in mania: A double-blind study of verapamil. Psychiatry Res. 18, 309-320 (1986).
14. Brotman, A.W., Farhadi, A.M. and Gelenberg, A.J.: Verapamil treatment of acute mania. J. Clin. Psychiatry 47, 136-138 (1986).
15. Dose, M., Emrich, H.M., Cording-Tommel, C. and von Zerssen, D.: Use of calcium antagonists in mania. Psychoneuroendocrinology 11, 241-243 (1986).
16. Solomon, L. and Williamson, P.: Verapamil in bipolar illness. Can. J. Psychiatry 31, 442-444 (1986).
17. Kennedy, S., Ozersky, S. and Robillard, M.: Refractory bipolar illness may not respond to verapamil. J. Clin. Psychopharmacol. 6, 316-317 (1986).
18. Giannini, A.J., Taraszewski, R. and Loiselle, R.H.: Verapamil and lithium as maintenance therapy of manic patients. J. Clin. Pharmacol. 27, 980-982 (1987).
19. Barton, B.M. and Gitlin, M.J.: Verapamil in treatment-resistant mania: An open trial. J. Clin. Psychopharmacol. 7, 101-103 (1987).
20. Patterson, J.F.: Treatment of acute mania with verapamil. J. Clin. Psychopharmacol. 7, 206 (1987).
21. Mathis, P., Schmitt, L. and Moron, P.: Efficacité du verapamil dans les accès maniaques. Encephale XIV, 127-132 (1988).
22. Dinan, T.G., Silverstone, T. and Cookson, J.C.: Cortisol, prolactin, and growth hormone levels with clinical ratings in manic patients treated with verapamil. Int. Clin. Psychopharmacol. 3, 151-156 (1988).
23. Brunet, G., Cerlich, B., Robert, P., Dumas, S., Souetre, F. and Darcourt, G.: Open trial of a calcium antagonist, nimodipine, in acute mania. Clin. Neuropharmacol 13, 224-228 (1990).
24. Deichen, R.F.: Verapamil treatment of bipolar depression. J. Clin. Psychopharmacol. 10, 148-149 (1990).
25. Johnson, B.A. and Cowen, P.J.: Calcium channel blockade and resistant bipolar depression. Irish J. Psychological. Med. 8, 50-51 (1991).
26. Garza-Trevino, E.S., Overall, J.E. and Hollister, L.E.: Verapamil versus lithium in acute mania. Am. J. Psychiatry 149, 121-122 (1992).
27. Lindelius, R. and Nilsson, C.G.: Fluanrizine as maintenance treatment of a patient with bipolar disorder. Am. J. Psychiatry 149, 139 (1992).
28. Kastner, T. and Freidman, D.L.: Verapamil and valproic acid treatment of prolonged mania. J. Am. Acad. Child Adolesc. Psychiatry 31, 271-275 (1992).
29. de Beaurepaire, R.: Treatment of neuroleptic resistant mania and schizoaffective disorders. Am. J. Psychiatry 149, 1614 (1993).
30. Goodnick, P.J.: Verapamil prophylaxis in pregnant women with bipolar disorder. Am. J. Psychiatry 150-156 (1993).
31. Pazzaglia, P.J., Post, R.M., Ketter, T.A., George, M.S. and Marangell, L.B.: Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation. Psychiatry Res. 49, 257-272 (1993).
32. Goodnick, P.: Nimodipine treatment of rapid cycling bipolar disorder. J. Clin. Psychiatry 56, 330 (1995).
33. Hoschl, C.: Verapamil for depression? Am. J. Psychiatry 140, 1100 (1983).
34. Eckmann, F.: Clinical double-blind study with the calcium antagonist flunarizine in cerebral circulatory disturbances. Arzneimittelforschung 35, 1276-1279 (1985).
35. Pollack, M.H. and Rosenbaum, J.F.: Verapamil in the treatment of recurrent unipolar depression. Biol. Psychiatry 22, 779-782 (1978).
36. Kramer, M.S., Caputo, K., Di Johnson, C, et al.: Negative trial of nifedipine in depression. Biol. Psychiatry 24, 958-959 (1988).
37. Hullett, F.T., Potkin, S.G., Levy, A.B. and Ciasc.a R.: Depression associated with nifedipine-induced calcium channel blockers. Am. J. Psychiatry 145, 1277-1279 (1988).
38. Hoschl, C. and Kozemy, J.: Verapamil in affective disorders: A controlled, double-blind study. Biol. Psychiatry 25, 128-140 (1989).
39. Eccleston, D. and Cole, A.J.: Calcium Channel blockade and depressive illness. Br. J. Psychiatry 156, 889-891 (1990).
40. Jacques, R.M. and Cox, S.J.: Verapamil in major (psychotic) depression. Br. J. Psychiatry 158, 124-125 (1991).
41. Walden, J., Fritze, J., VanCalker, D., Berger, M. and Grunse, H.: A calcium channel antagonist for the treatment of depressive episodes: Single case reports. J. Psychiatric Research 29, 71-76 (1995).
42. Grebb, J.A., Shelton, R.C., Taylor, E.H. and Bigelow, L.: A negative double-blind placebo-controlled clinical trial of verapamil in chronic schizophrenia. Biol. Psychiatry 21, 691-694 (1986).
43. Price, W.A.: Antipsychotic effects of verapamil in schizophrenia. Hillside J. Clinical Psychiatry 9, 225-230 (1987).
44. Pickar, D., Wolkwitz, O., Doran, A., Labarco, R., Roy, A., Breier, A. and Narong, P.C.: Clinical and biochemical effects of verapamil administration to schizophrenic patients. Arch. Gen. Psychiatry 44, 113-119 (1987).
45. Urh, S.B., Jackson, K. and Berger, P.A.: Effects of verapamil administration on negative symptoms of chronic schizophrenia. Psychiatry Res. 23, 551-352 (1988).
46. Bartko, G., Horvath, S., Zador, G. and Frecska, E.: Effects of adjunctive verapamil administration in chronic schizophrenic patients. Prog. Neuro-Psychopharmacol. Bio. Psychiatry 15, 343-349 (1991).
47. Klein, E. and Uhde, T.W.: Controlled study of verapamil for treatment of panic disorder. A.J. Psychiatry, 431-434 (1988).
48. Goldstein, J.A.: Calcium channel blockers in the treatment of panic disorders. J. Clin. Psychiatry 46, 546 (1985).
49. Goldstein, J.A.: Nifedipine treatment of Tourette's syndrome. J. Clin. Psychiatry 45, 360 (1984).
50. Berg, R.: A case of Tourette's syndrome treatment with nifedipine. Acta Psychiatrica Scandinavica 72, 400-401 (1985).
51. Walsh, T.L., Lavenstein, B., Licamele, W.I., Bronheim, S. and O'Leary, J.: Calcium antagonists in the treatment of Tourette's disorder. Am. J. Psychiatry 143, 1467-1468 (1986).
52. Barrow, N. and Childs, A.: An anti-tardive dyskinesia effect of verapamil. Am. J. Psychiatry 143, 1485 (1986).
53. Leys, D., Vermersch, P., Daniel, T., Comgras, S., Goudemand, M., Caron, J. and Petit, H.: Diltiazem for tardive dyskinesia. Lancet 1, 250-251 (1988).
54. Reiter, S., Adler R. and Angrist, B.: Effect of verapamil on tardive dyskinesia and psychosis in schizophrenic patients. J. Clin. Psychiatry 50, 26-27 (1989).
55. Walter, F.O., Young, A.B. and Rodnitsky, R.L.: Diltiazem in Huntington's disease. Neurology 25 (Suppl. I), 177 (1985).
56. Ban, T.A., Morey, I., Aguglia, E., Azzserelli, O., Balsana, F., Masrigliano, V., Caglieris, N., Sterlicchio, M., Apurso, A., Tomsi, N.A., Crepaldi, G., Volpe, D., Palmieri, G. Ambrosi, G., Polli, E., Cortellaro, M., Zanussy, C. and Froldi, M.: Nimodipine in the treatment of old age dementia. Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 14, 525-551 (1990).
57. Tollefson, G.D.: Short-term effects of the calcium channel blocker nimodipine (Baye-9736) in the management of primary degenerative dementia. Biol. Psychiatry 27, 1133-1142 (1991).
58. Dubovsky, S.L.: Why don't we hear more about the calcium antagonists? Biol. Psychiatry 35, 149-150 (1994).
59. Dubovsky, S.L.: Calcium channel antagonists as novel agents for manic-depressive disorder, in: Schatzberg, A.F. and Nemeroff, C.B. (Eds.): Textbook of Psychopharmacology. American Psychiatric Press, Washington, DC. 1995. pp 377-390.